期刊文献+

舒张性心力衰竭13例治疗体会

Treatment of 13 patients with diastolic heart failure
下载PDF
导出
出处 《武警医学》 CAS 2005年第12期908-910,共3页 Medical Journal of the Chinese People's Armed Police Force
  • 相关文献

参考文献8

  • 1Redfield MM. Understanding "diastolic" heart failure. N Engl J Med,2004,350 (19):1 930- 1 931.
  • 2Vasan RS, Levy D. Defining diastolic heart failure: acallforstandardized diagnostic criteria. Circulation, 2000,101 (17):2 118-2 121.
  • 3Aeschbacher BC, Hutter D, Fuhrer J et al . Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am JHypertens, 2001,14(2): 106 - 113.
  • 4Cha YM, Margaret MR, Shen WK et al . Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Circulation, 2004, 109(23):2 839-2 843.
  • 5Yusuf S, Sleight P, Pogue J, Bosch J et al . Effects of an angiotensin -converting enzyme inhibitor, ramipril, on cardiovascular events in high- risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000,342(3):145- 153.
  • 6Dahlof B, Devereux RB, Kjeldsen SE et al . Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, Lancet,2002,359(9 311) :995 - 1 003.
  • 7Pitt B, Zannad F, Remme WJ et al . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med, 1999,341 (10) :709 - 717.
  • 8Farquharson CA, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin Ⅰ/angiotensin Ⅱ conversion in patients with chronic heart failure. Circulation, 2000,101 (6) :594 - 597.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部